June 30, 2011 |
Accused Tucson gunman Jared Lee Loughner can be forced to take antipsychotic drugs while doctors attempt to make him fit to stand trial in the shooting of Rep. Gabrielle Giffords and 18 others, a federal judge ruled Wednesday. Loughner, 22, is accused of killing six and wounding 13 during a Jan. 8 rampage as Giffords was greeting constituents. The Arizona Democrat was shot in the head but survived. "I defer to medical doctors," U.S. District Judge Larry A. Burns said at an emergency hearing requested by the defense.
October 12, 2006 |
Drugs widely prescribed to control agitation, aggression, hallucinations or delusions in Alzheimer's patients provided few, if any, benefits and carried severe side effects, according to a large study released Wednesday. The findings challenged conventional wisdom about the medications and painted a grim picture of the state of Alzheimer's treatment. "We need a new generation of drugs for these very serious behaviors," said Dr. Thomas R.
November 2, 2011 |
Attorneys for the government and Jared Lee Loughner battled before a federal appeals court panel Tuesday over whether forcing antipsychotic drugs on the Tucson shooting defendant is legally justified and likely to restore his mental competency to stand trial on capital charges. In a complex debate citing the mere handful of similar cases in federal court archives, Assistant U.S. Atty. Christina M. Cabanillas told a three-judge panel of the U.S. 9th Circuit Court of Appeals that prison doctors, not judges and lawyers, were in the best position to decide what medications are needed to make Loughner fit for trial.
April 12, 2005 |
Elderly patients with dementia were significantly more likely to die prematurely if taking certain antipsychotic drugs, the government said in an advisory Monday to healthcare workers and patients. The Food and Drug Administration is asking manufacturers of atypical antipsychotic drugs to add to their labeling a boxed warning noting the risks and that the drugs were not approved to treat symptoms of dementia in the elderly.
February 6, 2006 |
Schizophrenics who took two antipsychotic drugs showed no more improvement than those on a single drug, raising doubts about the benefit of using multiple medicines to treat the disease, researchers have found. The study, published in the Feb. 2 issue of the New England Journal of Medicine, tested 68 patients who responded poorly to clozapine, the generic version of Novartis AG's Clozaril. Half the group took clozapine along with Johnson & Johnson's antipsychotic Risperdal.
May 30, 2012 |
A widely used antioxidant supplement can reduce some of the symptoms of autism in children, a pilot study has found. The supplement -- N-acetylcysteine, or NAC -- lowered irritability in the children and reduced repetitive behaviors, researchers from the Stanford University School of Medicine reported in the journal Biological Psychiatry. The team cautioned, however, that only 31 children were enrolled and that larger studies are needed to confirm the potential benefit. Currently, irritability, mood swings and depression in autistic children are treated with antipsychotic drugs.